RMD250117C160000
- 55.00
- 0.000.00%
ResMed Newsroom
Weekly Buzz: CES Came and Brought the Pain? That's Unexpected
Wall Street Today: Labor Gains Hurt a Hurting Market
This AppLovin Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
First Earnings Show Beats are Back, December Jobs Climbed but Market Falls Friday | Live Stock
ResMed Analyst Ratings
Piper Sandler Initiates ResMed(RMD.US) With Hold Rating, Announces Target Price $252
Balanced Outlook on ResMed: Strong Execution and Innovations Offset by Valuation Concerns and Market Challenges
Express News | Resmed Inc : Piper Sandler Initiates Coverage With Neutral Rating; Target Price $252
ResMed to Report Second Quarter Fiscal 2025 Earnings on January 30, 2025
Express News | Resmed to Report Second Quarter Fiscal 2025 Earnings on January 30, 2025
3 S&P 500 Earnings Growth Stocks to Buy in 2025: CMG, RMD, NOW
Resmed CFO Sells 1,000 Shares
Resmed Inc Officer Plans Further Sale of Common Shares
S&P 500 Positive for 'First Five Days,' Huang Sees Decades till Quantum | Wall Street Today
ResMed (RMD) Is an Incredible Growth Stock: 3 Reasons Why
Wednesday Market Falls, Quantum Computing Pulls Back Hard on Treasury Yield Crunch | Live Stock
Tuesday Market Pulls Back After Nvidia All Time High | Wall Street Today
Market Sells CES Tech News, ISM Tuesday as Nvidia Champions Robots Monday | Live Stock
HOLX Stock Gains Following the Acquisition of Gynesonics
Market Climbed Monday Just Past Santa Rally High Water Mark | Wall Street Today